ClinicalTrials.Veeva

Menu

Urine Gene Analysis for Pathogen Detection

D

David Sheyn

Status

Completed

Conditions

Urinary Tract Infections

Treatments

Diagnostic Test: Urine PCR testing

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT05591911
STUDY20220767

Details and patient eligibility

About

The objective of this study is the detection, quantification, and resistance gene identification of pathogens by using the urine of patients with urinary tract infection (UTI) symptoms.

Enrollment

96 patients

Sex

All

Ages

60+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult men and women 60 years and older who have urinary tract infection
  • Can participate in the informed consent process
  • Presenting to the clinic with symptoms of UTI or cystitis with no recent history of UTI within the past 21 days
  • Able to provide sufficient urine sample volume via clean catch or catheterization for urinalysis, conventional urine culture, and PCR
  • Understand and are willing to comply with the study requirements.
  • Sample collection able to be sent out the same day via courier

Exclusion criteria

  • Individuals under 60 years of age
  • Unable to provide informed consent
  • Urinary diversion of any type
  • Chronic indwelling urinary catheter
  • No recent history of UTI within the past 21 days
  • No antibiotic therapy within the past 21 days
  • No recent therapy with Phenazopyridine

Trial design

96 participants in 1 patient group

Patients over 60 years old presenting with acute urinary tract infection symptoms
Treatment:
Diagnostic Test: Urine PCR testing

Trial contacts and locations

1

Loading...

Central trial contact

Steven Madias; David Sheyn, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems